Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea among Children Younger Than 5 Years

  • Christopher Troeger
  • , Ibrahim A. Khalil
  • , Puja C. Rao
  • , Shujin Cao
  • , Brigette F. Blacker
  • , Tahmeed Ahmed
  • , George Armah
  • , Julie E. Bines
  • , Thomas G. Brewer
  • , Danny V. Colombara
  • , Gagandeep Kang
  • , Beth D. Kirkpatrick
  • , Carl D. Kirkwood
  • , Jason M. Mwenda
  • , Umesh D. Parashar
  • , William A. Petri
  • , Mark S. Riddle
  • , A. Duncan Steele
  • , Robert L. Thompson
  • , Judd L. Walson
  • John W. Sanders, Ali H. Mokdad, Christopher J.L. Murray, Simon I. Hay, Robert C. Reiner*
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

669 Citations (Scopus)

Abstract

Importance: Rotavirus infection is the global leading cause of diarrhea-associated morbidity and mortality among children younger than 5 years. Objectives: To examine the extent of rotavirus infection among children younger than 5 years by country and the number of deaths averted because of the rotavirus vaccine. Design, Setting, and Participants: This report builds on findings from the Global Burden of Disease Study 2016, a cross-sectional study that measured diarrheal diseases and their etiologic agents. Models were used to estimate burden in data-sparse locations. Exposure: Diarrhea due to rotavirus infection. Main Outcomes and Measures: Rotavirus-associated mortality and morbidity by country and year and averted deaths attributable to the rotavirus vaccine by country. Results: Rotavirus infection was responsible for an estimated 128500 deaths (95% uncertainty interval [UI], 104500-155600) among children younger than 5 years throughout the world in 2016, with 104733 deaths occurring in sub-Saharan Africa (95% UI, 83406-128842). Rotavirus infection was responsible for more than 258 million episodes of diarrhea among children younger than 5 years in 2016 (95% UI, 193 million to 341 million), an incidence of 0.42 cases per child-year (95% UI, 0.30-0.53). Vaccine use is estimated to have averted more than 28000 deaths (95% UI, 14600-46700) among children younger than 5 years, and expanded use of the rotavirus vaccine, particularly in sub-Saharan Africa, could have prevented approximately 20% of all deaths attributable to diarrhea among children younger than 5 years. Conclusions and Relevance: Rotavirus-associated mortality has decreased markedly over time in part because of the introduction of the rotavirus vaccine. This study suggests that prioritizing vaccine introduction and interventions to reduce diarrhea-associated morbidity and mortality is necessary in the continued global reduction of rotavirus infection..

Original languageEnglish
Pages (from-to)958-965
Number of pages8
JournalJAMA Pediatrics
Volume172
Issue number10
DOIs
Publication statusPublished - Oct 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea among Children Younger Than 5 Years'. Together they form a unique fingerprint.

Cite this